RGLS

Novartis completes acquisition of Regulus Therapeutics

PremiumThe Fly

7d ago

Novartis announces expiration of Regulus Therapeutics tender offer

PremiumThe Fly

7d ago

Novartis announces expiration of HSR waiting period of Regulus offer

PremiumThe Fly

9d ago

Cautious Hold Rating on Regulus Amid Merger Uncertainties and Strategic Developments

PremiumRatings

2M ago

PremiumCompany AnnouncementsRegulus Therapeutics to be Acquired by Novartis

2M ago

Regulus reports Q1 EPS (15c), consensus (26c)

The Fly

Regulus reports Q1 EPS (15c), consensus (26c)

2M ago

Pre-Earnings

RGLS Upcoming Earnings Report: What to Expect?

2M ago

Largest borrow rate increases among liquid names

PremiumThe Fly

2M ago

ABR

IEP

PremiumThe Fly

Regulus put volume heavy and directionally bearish

2M ago

Biotech Alert: Searches spiking for these stocks today

PremiumThe Fly

2M ago

Largest borrow rate increases among liquid names

ABEO

PremiumThe Fly

2M ago

ABR

ENB

PremiumThe FlyRegulus downgraded to Perform from Outperform at Oppenheimer

2M ago

Regulus downgraded to Market Perform from Outperform at Leerink

The Fly

Regulus downgraded to Market Perform from Outperform at Leerink

2M ago

Regulus downgraded to Equal Weight from Overweight at Wells Fargo

The Fly

Regulus downgraded to Equal Weight from Overweight at Wells Fargo

2M ago

Biotech Alert: Searches spiking for these stocks today

PremiumThe Fly

2M ago

Regulus downgraded to Hold from Buy at Canaccord

BCDA

PremiumThe Fly

2M ago

Regulus downgraded to Hold from Buy at JonesResearch

PremiumThe Fly

2M ago

Regulus Announces Merger Agreement with Novartis

PremiumCompany Announcements

2M ago

PremiumThe FlyRegulus to be acquired by Novartis for $7.00 per share in cash

2M ago

The Fly

Regulus to be acquired by Novartis for $7.00 per share in cash

2M ago

Ratings

Promising Phase 1b Results and Favorable Safety Profile Position Regulus’s Farabursen as a Strong Investment in ADPKD Treatment

3M ago